Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • News & Views
  • Published:

CANCER VACCINES

Towards a personalized iPSC-based vaccine

Nature Biomedical Engineering volume 2, pages 277–278 (2018)Cite this article

Subjects

A vaccine based on induced pluripotent stem cells mimicking the expression of tumour-cell antigens induces significant antitumour immune responses in mouse models.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Fig. 1: Inducing immunity against multiple cancer types by using an iPSC-based cancer vaccine.

References

  1. Brewer, B. G., Mitchell, R. A., Harandi, A. & Eaton, J. W. Exp. Mol. Pathol. 86, 192–197 (2009).

    Article  PubMed  CAS  Google Scholar 

  2. Schöne, G. Münch. Med. Wschr. 51, 2517–2519 (1906).

    Google Scholar 

  3. Ghosh, D., Mehta, N., Patil, A. & Sengupta, J. J. Reprod. Health Med. 2, S37–S47 (2016).

    Article  Google Scholar 

  4. Kooreman, N. G. et al. Cell Stem Cell 22, 501–513.e7 (2018).

    Article  PubMed  CAS  PubMed Central  Google Scholar 

  5. Ghosh, Z. et al. Cancer Res. 71, 5030–5039 (2011).

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  6. Goyvaerts, C. & Breckpot, K. J. Immunol. Res. 2015, 785634 (2015).

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  7. Wilgenhof, S. et al. Ann. Oncol. 24, 2686–2693 (2013).

    Article  PubMed  CAS  Google Scholar 

  8. Van Tendeloo, V. F. et al. Proc. Natl Acad. Sci. USA 107, 13824–13829 (2010).

    Article  PubMed  Google Scholar 

  9. Kissick, H. T. & Sanda, M. G. Curr. Opin. Immunol. 35, 15–22 (2015).

    Article  PubMed  CAS  Google Scholar 

  10. Sahin, U. et al. Nature 547, 222–226 (2017).

    Article  PubMed  CAS  Google Scholar 

  11. Agudo, J. et al. Immunity 48, 271–285.e5 (2018).

    Article  PubMed  CAS  Google Scholar 

  12. Golden, E. B. & Apetoh, L. Semin. Radiat. Oncol. 25, 11–17 (2015).

    Article  PubMed  Google Scholar 

  13. Greco, R. et al. Front. Pharmacol. 6, 95 (2015).

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  14. Inoue, H. et al. Blood 122, 4492 (2013).

    Google Scholar 

  15. Bode, C., Zhao, G., Steinhagen, F., Kinjo, T. & Klinman, D. M. Expert Rev. Vaccin. 10, 499–511 (2011).

    Article  CAS  Google Scholar 

  16. Kyi, C. & Postow, M. A. Immunotherapy 8, 821–837 (2016).

    Article  PubMed  PubMed Central  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Laboratory of Molecular and Cellular Therapy, Department of Biomedical Sciences, Vrije Universiteit Brussel, Brussels, Belgium

    Cleo Goyvaerts & Karine Breckpot

Authors
  1. Cleo Goyvaerts
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Karine Breckpot
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Karine Breckpot.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Goyvaerts, C., Breckpot, K. Towards a personalized iPSC-based vaccine. Nat Biomed Eng 2, 277–278 (2018). https://doi.org/10.1038/s41551-018-0237-7

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/s41551-018-0237-7

This article is cited by

Search

Advanced search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing